Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy.

Rong Y, Liu W, Wang J, Fan J, Luo Y, Li L, Kong F, Chen J, Tang P, Cai W. · 2019

Read Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy. by Rong Y, Liu W, Wang J, Fan J, Luo Y, Li L, Kong F, Chen J, Tang P, Cai W. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6472377.txt.

Introduction

Rong and co-authors test small extracellular vesicles from neural stem cells as a treatment for traumatic spinal cord injury in rats. The aim was stem cell benefits without transplanting cells that might die or turn tumorous. The vesicles were infused after injury and the animals followed for recovery.

Treated rats showed smaller lesions, better function, fewer dying neurons, and quieter microglia and inflammation. The vesicles switched on autophagy, raising LC3B and beclin-1 and forming more autophagosomes, while the death protein Bax and inflammatory cytokines fell and protective Bcl-2 rose. Adding the autophagy blocker 3MA undid the benefits, crediting self-digestion as the working mechanism.

Catalog record

CREATORRong Y, Liu W, Wang J, Fan J, Luo Y, Li L, Kong F, Chen J, Tang P, Cai W.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE66 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6472377

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy By Yuluo Rong, Wei Liu, Jiaxing Wang, Jin Fan, Yongjun Luo, Linwei Li, Fanqi Kong, Jian Chen, Pengyu Tang, Weihua Cai Published in: Cell Death & Disease DOI: 10.1038/s41419-019-1571-8 ABSTRACT Abstract Spinal cord injury (SCI) can cause severe irreversible motor dysfunction and even death. Neural stem cell (NSC) transplantation can promote functional recovery after acute SCI in experimental animals, but numerous issues, including low-transplanted cell survival rate, cell de-differentiation, and tumor formation need to be resolved before routine clinical application is feasible. Recent studies have shown that transplanted stem cells facilitate regeneration through release of paracrine factors. Small extracellular vesicles (sEVs), the smallest known membrane-bound nanovesicles, are involved in complex intercellular communication systems and are an important vehicle for paracrine delivery of therapeutic agents. However, the application of NSC-derived small extracellular vesicles (NSC-sEVs) to SCI treatment has not been reported. We demonstrate that NSC-sEVs can significantly reduce the extent of SCI, improve functional recovery, and reduce neuronal apoptosis, microglia activation, and neuroinflammation in rats. Furthermore, our study suggests that NSC-sEVs can regulate apoptosis and inflammatory processes by inducing autophagy. In brief, NSC-sEVs increased the expression of the autophagy marker proteins LC3B and beclin-1, and promoted autophagosome formation. Following NSC-sEV infusion, the SCI area was significantly reduced, and the expression levels of the proapoptotic protein Bax, the apoptosis effector cleaved caspase-3, and the pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 were significantly reduced, whereas the expression level of the anti-apoptotic protein Bcl-2 was upregulated. In the presence of the autophagy inhibitor 3MA, however, these inhibitory effects of NSC-sEVs on apoptosis and neuroinflammation were significantly reversed. Our results show for the first time that NSC-sEV treatment has the potential to reduce neuronal apoptosis, inhibit neuroinflammation, and promote functional recovery in SCI model rats at an early stage by promoting autophagy. Subject terms: Cell death in the nervous system, Neural stem cells, Neural stem cells, Neural stem cells, Neural stem cells INTRODUCTION Spinal cord injury (SCI) often leads to severe dysfunction of the limbs below the injured spinal segment, and more rostral (cervical injuries) may even be fatal1. The ultimate severity of SCI depends both on the initial trauma, which physically destroys neurons or severs axons, and on the extent of delayed secondary damage owing to inflammation, which can cause edema, neuronal apoptosis, cavitation, and reactive gliosis2,3. The treatment of SCI is rapidly evolving, and some experimental treatments have been examined in clinical trials. However, SCI remains largely irreversible and it is currently uncertain whether these therapies can safely improve prognosis4. Cell transplantation is one promising strategy to improve the recovery of motor, sensory, and/or autonomic function after SCI5,6. Neural stem cells (NSCs) have the ability to self-renew and produce neurons, oligodendrocytes, and astrocytes7–9. In recent years, NSC transplantation has become a major focus in the study of SCI repair10. Indeed, several studies have shown that NSC transplantation has a unique neuroprotective function that promotes functional recovery after acute SCI. The beneficial effects of NSC transplantation are mediated primarily by the promotion of regeneration, plasticity, and neurogenesis, and by the suppression of neuroinflammation11–13. However, direct transplantation of stem cells into target tissues remains challenging. For example, transplanted stem cells have a low survival rate owing to ischemia14. Other risks, such as cell de-differentiation, immune rejection, and tumor formation, further limit the clinical application of direct stem cell transplantation for the treatment of SCI15,16. Recent studies have shown that transplanted stem cells confer neuroprotection and promote repair primarily through a paracrine mechanism, and small extracellular vesicles (sEVs) play an important role in this process17. sEVs are the smallest endocytic membrane-bound nanovesicles18,19. They are released from many cell types under normal or pathological conditions and affect the activity of the recipient cells by delivery of various bioactive signaling molecules. sEVs contain cellular proteins and lipids involved in rapid signaling transduction as well as a host of functional mRNAs and microRNAs20. As stem cell secretions appear to be more beneficial for tissue regeneration and repair than living stem cells per se, NSC-derived small extracellular vesicles (NSC-sEVs) have been examined for therapeutic effects21. sEVs are enriched in specific microRNAs that regulate multiple functions under physiological and pathological conditions, including modulation of the direct microenvironment, promotion of viral entry into cells, metabolic signaling, and regulation of diverse aspects of brain function in adulthood including the process of aging22–25. In addition, NSC-derived extracellular vesicles are used to treat a variety of neurodegenerative diseases owing to their anti-inflammatory, neurogenic, and neurotrophic effects26–28. Therefore, we believe that sEVs from NSCs may also promote functional recovery after traumatic SCI. Studies have shown that autophagy is critical for protection against SCI29,30, possibly owing to the re-routing of metabolic substrates for repair. There is dynamic feedback between autophagy and cellular energy balance31. Autophagy has an important role not only in maintaining the supply of nutrients required for cell survival, but also as a regulator of cytoplasmic quality control by eliminating long-lived or unfolded proteins and impaired organelles32,33. In addition, autophagy induced by human umbilical cord mesenchymal stem cell-derived sEVs can effectively alleviate the nephrotoxicity of cisplatin34. These studies suggest that activation of autophagy can reduce tissue damage. However, it is unclear whether NSC-sEVs can activate autophagy. Here, we show for the first time that NSC-sEVs have the potential to reduce neuronal apoptosis, inhibit neuroinflammation, and promote functional recovery in SCI model rats by activating autophagy. MATERIAL AND METHODS Isolation and purification of NSC-sEVs NSCs were obtained from 13.5-day fetal mouse spinal cord and cultured in growth medium with 2% N2 (Gibco, Grand Island, NY, USA), 1% B27 (R&D Systems, Minneapolis, MN, USA), bFGF 20 ng/ml (R&D Systems), and EGF 20 ng/ml (R&D Systems). The growth medium was collected and centrifuged at 300 g for 10 min, followed by centrifugation at 2000 × g for 10 min at 4 °C. After centrifugation, the medium supernatant was sterilized by filtration through a 0.22 μm filter to remove cellular debris. The upper compartment of the supernatant was then transferred to an Amicon Ultra-15 centrifugal filter (Millipore, Burlington, MA, USA) and centrifuge at 4000 × g at 4 °C until the volume of the upper chamber was reduced to ~ 200 μL. The ultrafiltrate was washed twice with phosphate-buffered saline (PBS) and ultrafiltered again to 200 μL. For sEV purification, the medium was loaded on a 30% sucrose/D2O pad in a sterile Ultra-ClearTM tube (Beckman Coulter, Asphalt, CA, USA) and centrifuged at 4 °C for 60 min at 100,000 × g using an optima L-100 XP Ultracentrifuge (Beckman Coulter). Partially purified NSC-sEVs were recovered using an 18 g needle, diluted in PBS, and centrifuged at 4 °C/4000 × g through the filter unit until the final volume reached 200 μL. The solution was stored at −80 °C or used immediately for experiments. The NSC-sEV protein content was determined using a bicinchoninic acid assay (BCA; Thermo Fisher Scientific, Waltham, MA) by measuring absorbance at 562 nm. Characterization of NSC-sEVs To analyze the morphological characteristics of sEVs, a three-dimensional map of particle size, solid shape, and relative intensity was constructed using NanosizerTM (Malvern Instruments, Malvern, UK). The morphology of the obtained sEVs was

Read the complete text